David Ledbetter is chief clinical officer of Dascena, a personalized medicine company.
David Ledbetter
Chief clinical officer
Dascena
From this contributor
There are no autism-specific genes, just brain genes
There is not yet a single example of a gene that, when mutated, increases the likelihood of autism but not of other neurodevelopmental conditions, including intellectual disability.
There are no autism-specific genes, just brain genes
Developmental disorders should be viewed as continuum
Intellectual disability, autism, epilepsy and schizophrenia should be considered part of a spectrum of developmental brain dysfunction, says David Ledbetter.
Developmental disorders should be viewed as continuum
Explore more from The Transmitter
‘Neuroethics: The Implications of Mapping and Changing the Brain,’ an excerpt
In his new book, published today, philosopher Walter Glannon examines the ethics of six areas of neuroscience. In Chapter 4, a portion of which appears below, he tackles the ethical considerations of using brain organoids in research.
‘Neuroethics: The Implications of Mapping and Changing the Brain,’ an excerpt
In his new book, published today, philosopher Walter Glannon examines the ethics of six areas of neuroscience. In Chapter 4, a portion of which appears below, he tackles the ethical considerations of using brain organoids in research.
Teasing out mosaicism cell by cell; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 10 November.
Teasing out mosaicism cell by cell; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 10 November.
Without monkeys, neuroscience has no future
Research in primate brains has been essential for the development of brain-computer interfaces and artificial neural networks. New funding and policy changes put the future of such advances at risk.
Without monkeys, neuroscience has no future
Research in primate brains has been essential for the development of brain-computer interfaces and artificial neural networks. New funding and policy changes put the future of such advances at risk.